During the past decade, Zengeza CRS conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zengeza CRS" #1 collaborator was "Microbicide Trials Network" with 2 trials as a collaborator, "Ministry of Health and Child Welfare, Zimbabwe" with 2 trials as a collaborator, "Centers for Disease Control and Prevention" with 1 trials as a collaborator, "EQUIP Innovation for Health" with 1 trials as a collaborator and "Family Health International (FHI 360)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Zengeza CRS" are "HIV Infections" (5 trials), "COVID-19" (1 trials), "HIV Seropositivity" (1 trials), "HIV/AIDS" (1 trials) and "SARS-CoV-2" (1 trials). Many other conditions were trialed in "Zengeza CRS" in a lesser frequency.

Most popular intervention types in "Zengeza CRS" are "Drug" (5 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Emtricitabine/tenofovir disoproxil fumarate" (2 trials), "Emtricitabine/tenofovir disoproxil fumarate placebo" (2 trials), "Tenofovir disoproxil fumarate" (2 trials), "Tenofovir disoproxil fumarate placebo" (2 trials) and "Truvada Tablet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zengeza CRS" are 4 trials for "Female" genders, 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Zengeza CRS". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Zengeza CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zengeza CRS, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".